Analog chip manufacturer Texas Instruments (NASDAQ:TXN) will be reporting results tomorrow after market hours. Here's what to look for.
Last quarter Texas Instruments reported revenues of $5.21 billion, up 13.7% year on year, beating analyst revenue expectations by 12.1%. It was a solid quarter for the company, with impressive beat of analyst estimates and strong sales guidance for the next quarter.
Is Texas Instruments buy or sell heading into the earnings? Read our full analysis here, it's free.
This quarter analysts are expecting Texas Instruments's revenue to grow 10.6% year on year to $5.13 billion, slowing down from the 21.6% year-over-year increase in revenue the company had recorded in the same quarter last year. Adjusted earnings are expected to come in at $2.42 per share.
Majority of analysts covering the company have reconfirmed their estimates over the last thirty days, suggesting they are expecting the business to stay the course heading into the earnings. The company only missed Wall St's revenue estimates once over the last two years, and has on average exceeded top line expectations by 7.56%.
With Texas Instruments being the first among its peers to report earnings this season, we don't have anywhere else to look at to get a hint at how this quarter will unravel for semiconductor stocks, but investors in the semiconductor segment have had steady hands going into the earnings, with the stocks up on average 0.32% over the last month. Texas Instruments is down 0.25% during the same time, and is heading into the earnings with analyst price target of $177.40, compared to share price of $160.05.
One way to find opportunities in the market is to watch for generational shifts in the economy. Almost every company is slowly finding itself becoming a technology company and facing cybersecurity risks and as a result, the demand for cloud-native cybersecurity is skyrocketing. This company is leading a massive technological shift in the industry and with revenue growth of 70% year on year and best-in-class SaaS metrics it should definitely be on your radar.
The author has no position in any of the stocks mentioned.